Phosphodiesterase 5 Inhibitors Enhance Chemotherapy Killing in Gastrointestinal/Genitourinary Cancer Cells-Reference-Cited by-同舟云学术

Phosphodiesterase 5 Inhibitors Enhance Chemotherapy Killing in Gastrointestinal/Genitourinary Cancer Cells

Published:2013-12-18 Issue:3 Volume:85 Page:408-419
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Booth Laurence,Roberts Jane L.,Cruickshanks Nichola,Conley Adam,Durrant David E.,Das Anindita,Fisher Paul B.,Kukreja Rakesh C.,Grant Steven,Poklepovic Andrew,Dent Paul

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference54 articles.

1. Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation

2. CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?

3. Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells

4. Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use

5. PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors;Anti-Cancer Drugs;2024-03-08

2. Cancer Metabolism as a Therapeutic Target and Review of Interventions;Nutrients;2023-10-01

3. Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives;Pharmaceuticals;2023-09-06

4. The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers;MedComm;2023-08

5. Immunomodulatory, apoptotic and anti-proliferative potentials of sildenafil in Ehrlich ascites carcinoma murine model: In vivo and in silico insights;International Immunopharmacology;2023-06